Applied Therapeutics, Inc.
APLT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $12 | $30 | $51 | $79 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $17 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $3 | $4 | $3 | $4 |
| Total Curr. Assets | $32 | $35 | $54 | $84 |
| Property Plant & Equip (Net) | $2 | $3 | $3 | $3 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $3 | $3 | $3 | $3 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $34 | $37 | $57 | $87 |
| Liabilities | – | – | – | – |
| Payables | $5 | $5 | $5 | $4 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $27 | $12 | $12 | $22 |
| Total Curr. Liab. | $33 | $18 | $18 | $27 |
| LT Debt | $2 | $2 | $2 | $2 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $2 | $2 | $2 | $2 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $3 | $3 | $3 | $3 |
| Total Liabilities | $35 | $20 | $20 | $30 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$636 | -$617 | -$596 | -$574 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $636 | $635 | $633 | $631 |
| Total Equity | -$1 | $17 | $37 | $57 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $34 | $37 | $57 | $87 |
| Net Debt | -$9 | -$28 | -$48 | -$77 |